Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Osteoporos Int ; 6(2): 127-9, 1996.
Article in English | MEDLINE | ID: mdl-8704350

ABSTRACT

In order to study the action of tiludronate on the changes in intraosseous vascularization induced by ovariectomy, and to link these effects to those observed in bone remodelling, 30 female Sprague-Dawley rats (age 40 weeks) were studied. Ten rats were shamoperated and treated by vehicle, 10 rats were ovariectomized and treated by vehicle, and 10 rats were ovariectomized and treated orally with tiludronate, 0.16 mmol/kg/per day, 3 days a week for 16 weeks, from the day following ovariectomy. The rats were killed after 4 months, and a histomorphometric study and quantification of intraosseous vessels carried out on the sixth lumbar vertebra. The area of the intraosseous sinusoidal capillaries increased after ovariectomy, which also induced a moderate increase in resorption surfaces and osteoid surfaces leading to a decrease of 40% in the trabecular bone volume at the lumbar spine level. This bone mineral loss was completely prevented by tiludronate, which normalized the bone turnover. However, tiludronate was without any effect on intraosseous vascularization. These results indicate that the surface area of the intraosseous sinusoidal capillaries was correlated positively with resorption surfaces and negatively with trabecular bone volume and the number of bone trabeculae. In these experimental conditions, an inhibitor of bone resorption can exert its positive effect on bone mass without normalization of vascularization.


Subject(s)
Bone Remodeling/drug effects , Diphosphonates/pharmacology , Lumbar Vertebrae/blood supply , Ovariectomy , Animals , Blood Flow Velocity , Bone Resorption/blood , Bone Resorption/etiology , Bone Resorption/prevention & control , Bone and Bones , Capillaries/drug effects , Capillaries/pathology , Estradiol/blood , Female , Lumbar Vertebrae/drug effects , Rats , Rats, Sprague-Dawley
2.
Agents Actions ; 19(5-6): 341-3, 1986 Dec.
Article in English | MEDLINE | ID: mdl-3825752

ABSTRACT

Hairless rats with dermatosis induced with a poor magnesium diet were previously shown to bear biochemical and immunological abnormalities. It was therefore felt of interest to investigate the spleen cells proliferative responses from these rats, both in the rash and the remission phases, when testosterone and parathormone plasma levels were also determined. Results showed that proliferative responses to mitogens and PTH levels were inversely related to the intensity of the dermatosis, whereas testosterone levels were more or less decreased. The role of 1.25 dihydroxyvitamin D3 in these modifications is questionable.


Subject(s)
Lymphocyte Activation , Magnesium Deficiency/immunology , Skin Diseases/immunology , Spleen/immunology , Animals , Magnesium Deficiency/blood , Male , Parathyroid Hormone/blood , Rats , Skin Diseases/etiology , Testosterone/blood
3.
Agents Actions ; 17(3-4): 352-4, 1986 Jan.
Article in English | MEDLINE | ID: mdl-3962783

ABSTRACT

Dermatosis in magnesium-deficient hairless rats has been described as a reproducible model of skin inflammation. It was therefore felt of interest to search for the effects of various anti-inflammatory compounds on this model. Results showed that 1) Dexamethasone acetate completely abolished the rash, 2) Indomethacin, a Non-Steroidal Anti-Inflammatory Drug (NSAID), inhibitor of the cyclooxygenase pathway was quite inactive, 3) Benoxaprofen, a NSAID inhibitor of both cyclooxygenase and lipoxygenase pathways only slightly modified the development of the pathology. Activity of steroidal anti-inflammatory drugs on this model may be related to their immunosuppressive effects.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dermatitis/drug therapy , Magnesium Deficiency/complications , Steroids/therapeutic use , Animals , Dermatitis/etiology , Dexamethasone/therapeutic use , Diet , Indomethacin/therapeutic use , Magnesium/blood , Male , Mice , Mice, Hairless , Propionates/therapeutic use , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...